Literature DB >> 19797754

The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old.

Liyuan Ma1, Antoine C El Khoury, Robbin F Itzler.   

Abstract

OBJECTIVES: We sought to compare the burden of hospitalizations associated with rotavirus gastroenteritis (RGE) in children younger than 5 years in US Medicaid and non-Medicaid populations in 2000 and 2003.
METHODS: We used the Kids' Inpatient Database (KID) to examine the burden of RGE-associated hospitalizations in terms of numbers and rates of hospitalizations, lengths of stay, and hospital charges. Two indirect methods were also used to estimate RGE-associated hospitalizations, because rotavirus testing is not routinely performed.
RESULTS: Approximately 40% of children younger than 5 years were enrolled in Medicaid in 2003, but this population accounted for nearly 50% of all RGE-associated hospitalizations and 60% of total charges. Children enrolled in Medicaid had significantly greater hospitalization rates, average lengths of stay, and average charges per stay than did those not enrolled.
CONCLUSIONS: Although RGE affects all socioeconomic groups, the Medicaid population accounted for a disproportionate number of the hospitalizations. With the inclusion of rotavirus vaccines in the pediatric immunization schedule, it is important that US children, especially those enrolled in Medicaid programs, are vaccinated to reduce the burden of RGE.

Entities:  

Mesh:

Year:  2009        PMID: 19797754      PMCID: PMC4504389          DOI: 10.2105/AJPH.2008.148494

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  29 in total

1.  Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Authors:  A W Tucker; A C Haddix; J S Bresee; R C Holman; U D Parashar; R I Glass
Journal:  JAMA       Date:  1998-05-06       Impact factor: 56.272

2.  The effect of continuity of care on emergency department use.

Authors:  J M Gill; A G Mainous; M Nsereko
Journal:  Arch Fam Med       Date:  2000-04

3.  Rotavirus as a cause of diarrheal morbidity and mortality in the United States.

Authors:  M S Ho; R I Glass; P F Pinsky; L J Anderson
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

4.  Rotavirus immunoglobulin levels among Indian mothers of two socio-economic groups and occurrence of rotavirus infections among their infants up to six months.

Authors:  Pratibha G Ray; Shobhana D Kelkar; Atul M Walimbe; Vaishali Biniwale; Savita Mehendale
Journal:  J Med Virol       Date:  2007-03       Impact factor: 2.327

5.  Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Authors:  Marc-Alain Widdowson; Martin I Meltzer; Xinzhi Zhang; Joseph S Bresee; Umesh D Parashar; Roger I Glass
Journal:  Pediatrics       Date:  2007-04       Impact factor: 7.124

6.  Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003.

Authors:  Thea Kølsen Fischer; Cécile Viboud; Umesh Parashar; Mark Malek; Claudia Steiner; Roger Glass; Lone Simonsen
Journal:  J Infect Dis       Date:  2007-03-06       Impact factor: 5.226

7.  Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children.

Authors:  Vincent P Hsu; Mary Allen Staat; Nancy Roberts; Carla Thieman; David I Bernstein; Joseph Bresee; Roger I Glass; Umesh D Parashar
Journal:  Pediatrics       Date:  2005-01       Impact factor: 7.124

Review 8.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey.

Authors:  Philip J Smith; Ben Schwartz; Ali Mokdad; Alan B Bloch; Mary McCauley; Trudy V Murphy
Journal:  Public Health Rep       Date:  2003 Mar-Apr       Impact factor: 2.792

10.  Pediatric viral gastroenteritis during eight years of study.

Authors:  C D Brandt; H W Kim; W J Rodriguez; J O Arrobio; B C Jeffries; E P Stallings; C Lewis; A J Miles; R M Chanock; A Z Kapikian; R H Parrott
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

View more
  7 in total

1.  Case fatality and population mortality associated with anaphylaxis in the United States.

Authors:  Larry Ma; Theodore M Danoff; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2013-12-14       Impact factor: 10.793

2.  Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.

Authors:  Catherine A Panozzo; Sylvia Becker-Dreps; Virginia Pate; David J Weber; Michele Jonsson Funk; Til Stürmer; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2014-02-26       Impact factor: 4.897

3.  Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.

Authors:  Sarah B Whittle; Michelle A Lopez; Heidi V Russell
Journal:  Pediatr Blood Cancer       Date:  2019-04-16       Impact factor: 3.167

4.  Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.

Authors:  Anaam Mohammed; Lilly Immergluck; Trisha Chan Parker; Shabnam Jain; Traci Leong; Evan J Anderson; Robert C Jerris
Journal:  Vaccine       Date:  2015-08-29       Impact factor: 3.641

5.  Rotavirus-associated hospitalization and emergency department costs and rotavirus vaccine program impact.

Authors:  April Kilgore; Stephanie Donauer; Kathryn M Edwards; Geoffrey A Weinberg; Daniel C Payne; Peter G Szilagyi; Marilyn Rice; Amy Cassedy; Ismael R Ortega-Sanchez; Umesh D Parashar; Mary Allen Staat
Journal:  Vaccine       Date:  2013-07-08       Impact factor: 3.641

6.  Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States.

Authors:  Girishanthy Krishnarajah; Kitaw Demissie; Patrick Lefebvre; Sunanda Gaur; Mei Sheng Duh
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Socioeconomic status is associated with symptom severity and sickness absence in people with infectious intestinal disease in the UK.

Authors:  Tanith C Rose; Natalie L Adams; Benjamin Barr; Jeremy Hawker; Sarah J O'Brien; Mara Violato; Margaret Whitehead; David C Taylor-Robinson
Journal:  BMC Infect Dis       Date:  2017-06-23       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.